Unsafe abortion remains a pressing public health crisis in Kenya, contributing significantly to high maternal mortality rates in the country. The Kenya Obstetrical and Gynaecological
4th October 2024 The announcement by Gilead that six generic manufacturers have been awarded voluntary licenses for the production of lenacapavir—a groundbreaking, twice-yearly injectable for
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok